<DOC>
	<DOCNO>NCT00162877</DOCNO>
	<brief_summary>The objective trial find rationale optimal dose duration regimen eradication H. pylorus infection use different proton pump inhibitor .</brief_summary>
	<brief_title>The Role CYP2C19 Eradication H. Pylori Infection : Implication PK/PD Relationships</brief_title>
	<detailed_description>Helicobacter pylorus know closely associate pathogenesis gastroduodenal disorder peptide ulcer . Eradication bacterium important treatment disease well reduction recurrence . The one-week triple therapy proton pump inhibitor ( PPIs ) consider standard therapy treatment Helicobacter pylorus infection , provide 80 % eradication rate adverse effect . PPIs mainly metabolize CYP2C19 , know exhibit polymorphisms genotype phenotype . Based PK/PD result study PPI , recently , propose CYP2C19 poor metabolizers might subject advantageous condition , especially day-4 , treatment H. pylori infection 20 mg rabeprazole give twice daily . Our result also suggest possibility start triple therapy day-4 rabeprazole treatment ensure optimal acid suppression effect antibiotic exert bacteriocidal effect . To find rationale optimal dose regimen eradication H. pylorus infection use different proton pump inhibitor , volunteer four group would include study . PPI ( rabeprazole esomeprazole ) give 7 day . Antibiotics give start day-1 day-4 PPI dosing . The eradication rate H. pylorus infection PK/PD PPIs also evaluate .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Male female dyspeptic patient H. pyloripositive peptic ulcer gastritis recruit university hospital study . 1 ) Pregnant lactate female ; *2 ) Patients endoscopybased evidence gastric malignancy , pyloric obstruction , esophageal stricture require dilation , fresh clot , active bleeding , perforated ulcer ; 3 ) Patients require anticoagulant corticosteroid therapy ( dosage great equivalent prednisone , 10 mg/day ) ; 4 ) Patients significant impairment renal function ( creatinine &gt; 2mg/dl ) ; liver function impairment ( AST ALT 2x upper limit normal ) ; severe cardiac disease , e.g . angina pectoris , myocardial infarction , cardiac arrhythmia , congestive heart failure ( New York Heart Association Functional Classification III IV ) acute respiratory disease ; 5 ) Patients history esophageal and/or gastric varix ; 6 ) Use investigational drug within 30 day prior study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2004</verification_date>
	<keyword>rabeprazole , omeprazole , CYP2C19 , H. pylorus , PK/PD</keyword>
</DOC>